Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

Most of us don’t wake up dreaming about joining a clinical trial. For decades, research was something that happened to other people: the hyper-healthy, the terminally curious, folks with more time on ...

Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...

Avik Pal, Founder and CEO of CliniOps, a technology and data company with a patented unified platform approach to digitize clinical trials. I think the aphorism "rising tides lift all boats" is an apt ...

Adaptive workflow systems represent a significant departure from rigid, process-centric approaches. Instead of imposing a linear, step-by-step structure, teams will be able to dynamically assign and ...

A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...

Greenwich LifeSciences reports preliminary HLA data from Phase III trial FLAMINGO-01 evaluating GLSI-100 for preventing breast cancer recurrences. Greenwich LifeSciences, Inc. provided an update on ...

Management indicated they "plan to deliver multiple near-term updates that assess blood-based biomarkers of metabolic health, body composition and weight loss across multiple cohorts." Data from the ...

“We are excited to present, backed up by published clinical data, oral, once daily blarcamesine with its upstream mechanism of action restoring autophagy - the key driver in restoring cellular ...